Victor A. Chow

892 total citations
29 papers, 359 citations indexed

About

Victor A. Chow is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Victor A. Chow has authored 29 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Victor A. Chow's work include CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Victor A. Chow is often cited by papers focused on CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Victor A. Chow collaborates with scholars based in United States, South Africa and Japan. Victor A. Chow's co-authors include Ajay K. Gopal, Mazyar Shadman, Deven Patel, Suman Mukhopadhyay, Deepak Menon, David A. Foster, Mahesh Saqcena, Filippo Milano, Wendy M. Leisenring and Michael Boeckh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Victor A. Chow

27 papers receiving 353 citations

Peers

Countries citing papers authored by Victor A. Chow

Since Specialization

Citations

This map shows the geographic impact of Victor A. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor A. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor A. Chow more than expected).

Fields of papers citing papers by Victor A. Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor A. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor A. Chow. The network helps show where Victor A. Chow may publish in the future.

Co-authorship network of co-authors of Victor A. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Victor A. Chow. A scholar is included among the top collaborators of Victor A. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor A. Chow. Victor A. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis 2024 ·Transplantation and Cellular Therapy ·Christina Poh, Victor A. Chow, Ryan C. Lynch, Chaitra S. Ujjani, Edus H. Warren, Mazyar Shadman, Brian G. Till, (unknown), Jordan Gauthier, Alexandre V. Hirayama, Stephen D. Smith, Taranjit S. Gujral, Chihiro Morishima, (unknown), Jenna Voutsinas, (unknown), David G. Maloney, Ajay K. Gopal	0
2	Lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) with salvage chemotherapy (CT) followed by autologous stem cell transplantation (ASCT) as second-line (2L) treatment in patients (pt) with R/R large B-cell lymphoma (LBCL): 3-year follow-up (FU) from the randomized, phase 3 TRANSFORM study. 2024 ·Journal of Clinical Oncology ·Manali Kamdar, Scott R. Solomon, Jon Arnason, Patrick B. Johnston, Bertram Glaß, Veronika Bachanová, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco J. Hernandez‐Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, Victor A. Chow, (unknown), Silvia Colicino, K. OGASAWARA, Lara Stepan, Jeremy S. Abramson	6
3	Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis 2023 ·Blood ·Christina Poh, Victor A. Chow, Ryan C. Lynch, Chaitra S. Ujjani, Mazyar Shadman, Brian G. Till, (unknown), Edus H. Warren, Jordan Gauthier, Stephen D. Smith, Taranjit S. Gujral, Chihiro Morishima, Qian Wu, Jenna Voutsinas, (unknown), (unknown), David G. Maloney, Ajay K. Gopal	1
4	Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant 2022 ·Bone Marrow Transplantation ·Chikara Ogimi, Elizabeth M. Krantz, Jonathan L. Golob, Catherine Liu, Alpana Waghmare, (unknown), (unknown), Wendy M. Leisenring, Keith R. Jerome, Victor A. Chow, Steven A. Pergam, David N. Fredricks, Janet A. Englund, Michael Boeckh	6
5	Predictors of response to axicabtagene‐ciloleucel CAR T cells in aggressive B cell lymphomas: A real‐world study 2022 ·Journal of Cellular and Molecular Medicine ·Lorenzo Iovino, Qian Wu, Jenna Voutsinas, (unknown), Erin Mullane, Ryan C. Lynch, Chaitra S. Ujjani, Stephen D. Smith, Ajay K. Gopal, Brian G. Till, Filippo Milano, Victor A. Chow, Jordan Gauthier, Cameron J. Turtle, David G. Maloney, Mazyar Shadman	9
6	Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma 2022 ·Leukemia & lymphoma ·(unknown), Qian Wu, Jenna Voutsinas, Erin Mullane, Victor A. Chow, Ryan C. Lynch, Chaitra S. Ujjani, Stephen D. Smith, Ajay K. Gopal, Christina Poh, Lorenzo Iovino, Cameron J. Turtle, David G. Maloney, Brian G. Till, Jordan Gauthier, Mazyar Shadman	1
7	Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma 2020 ·Transplantation and Cellular Therapy ·Sherilyn A. Tuazon, Ryan D. Cassaday, Theodore A. Gooley, Brenda M. Sandmaier, Leona Holmberg, Stephen D. Smith, David G. Maloney, Brian G. Till, Daniel B. Martin, Victor A. Chow, Joseph G. Rajendran, Darrell R. Fisher, Manuela C. Matesan, (unknown), Damian J. Green, John M. Pagel, Oliver W. Press, Ajay K. Gopal	5
8	Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation 2020 ·Biology of Blood and Marrow Transplantation ·Mehdi Hamadani, (unknown), Kwang Woo Ahn, Carlos Litovich, Victor A. Chow, (unknown), Reem Karmali, Allison Winter, Timothy S. Fenske, Craig S. Sauter, Mohamed A. Kharfan‐Dabaja, Farrukh T. Awan	7
9	A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma 2020 ·American Journal of Hematology ·Victor A. Chow, Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Ryan D. Cassaday, Paul S. Martin, Leona Holmberg, Theodore A. Gooley, Philip A. Stevenson, John M. Pagel, Damian J. Green, Oliver W. Press, Ajay K. Gopal	7
10	Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy 2020 ·Blood Advances ·Victor A. Chow, Ajay K. Gopal, Jordan Gauthier, Yolanda D. Tseng, Cameron J. Turtle, David G. Maloney, Mazyar Shadman	9
11	Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease 2019 ·Biology of Blood and Marrow Transplantation ·(unknown), Victor A. Chow, Catherine Liu, Lori Bourassa, (unknown), (unknown), (unknown), Barry E. Storer, Marco Mielcarek, Steven A. Pergam	8
12	High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials 2019 ·Blood ·Manoj Menon, Victor A. Chow, Adam Greenbaum, Ryan C. Lynch, Mazyar Shadman, Andrei R. Shustov, Stephen D. Smith, Brian G. Till, Yolanda D. Tseng, Chaitra S. Ujjani, Thomas S. Uldrick, Edus H. Warren, Ajay K. Gopal	4
13	Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes 2019 ·Blood ·Mazyar Shadman, Jordan Gauthier, Sirin Khajavian, Alexandre V. Hirayama, Ryan C. Lynch, Stephen D. Smith, Chaitra S. Ujjani, Victor A. Chow, Hans‐Peter Kiem, Brian G. Till, Ajay K. Gopal, David G. Maloney, Cameron J. Turtle	4
14	Where does transplant fit in the age of targeted therapies? 2019 ·Hematology ·Victor A. Chow, Ajay K. Gopal	1
15	Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma 2018 ·Blood ·Victor A. Chow, Mazyar Shadman, Ajay K. Gopal	101
16	Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy 2018 ·Blood ·Victor A. Chow, Ajay K. Gopal, David G. Maloney, Cameron J. Turtle, Stephen D. Smith, Mazyar Shadman, Ryan D. Cassaday, Brian G. Till, Yolanda D. Tseng, Edus H. Warren, Andrei R. Shustov, Manoj Menon, Sandra Kanan, Utkarsh Acharya, Erin Mullane, Lindsay M. Hannan, Jenna Voutsinas, Ted Gooley, Ryan C. Lynch	13
17	Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML) 2013 ·Leukemia Research Reports ·Victor A. Chow, Kathleen Shannon Dorcy, (unknown), Kelda M. Gardner, Pamela S. Becker, John M. Pagel, Paul C. Hendrie, Janis L. Abkowitz, Frederick R. Appelbaum, Elihu H. Estey	3
18	Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle 2013 ·PLoS ONE ·Mahesh Saqcena, Deepak Menon, Deven Patel, Suman Mukhopadhyay, Victor A. Chow, David A. Foster	61
19	CUA Guideline: The workup of azoospermic males 2013 ·Canadian Urological Association Journal ·Keith Jarvi, Kirk Lo, Anthony J. Fischer, John Grantmyre, Armand Zini, Victor A. Chow, Victor Mak	1
20	Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients 2011 ·Blood ·Filippo Milano, Steven A. Pergam, Hu Xie, Wendy M. Leisenring, Jonathan A. Gutman, (unknown), Victor A. Chow, Michael Boeckh, Colleen Delaney	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact